Argeris N. Karabelas, Director at Vanda Pharmaceuticals Inc. (VNDA), sold 200,000 shares at $11.80 ($2.4M) on 2010-03-12, disclosed to the SEC on 2010-03-15.
Open-market sale of $2.4M VNDA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RGNX | SELL | 2024-08-05 | $136K | — | Filing → |
| RGNX | SELL | 2024-07-30 | $166K | — | Filing → |
| RGNX | SELL | 2024-07-03 | $113K | — | Filing → |